Ferring Pharmaceuticals
Kim Hartmann Jannsen serves as the Senior Director of PMO and Portfolio Management at Ferring Pharmaceuticals since March 2008, where notable achievements include designing and executing strategic programs within the global pharmaceutical development organization. Previous roles at Ferring include Director of Strategy & Business Performance and Director of Global CMC Business Support, focusing on enhancing operational efficiencies and decision-making processes. Kim's career also includes positions as Controller at Chr. Hansen A/S, Finance Manager at UNI2 A/S, Financial Controller at Bayer A/S, Senior Assistant in Auditing at Deloitte & Touche International, and Assistant Controller at Bella Center A/S. Kim holds an M.Sc. in Business Economics and Auditing and a B.Sc. in Economics and Business Administration from Copenhagen Business School.
This person is not in any teams
This person is not in any offices
Ferring Pharmaceuticals
16 followers
Ferring Holding SA, better known as Ferring Pharmaceuticals, is a multinational pharmaceutical company that specializes in the development and marketing of drugs for use in human medicine.